A new type of tuberculosis treatment that involves manipulating the body’s response to TB bacteria rather than targeting the bacteria themselves — a concept called host-directed therapy — has been established by researchers. TB remains a major cause of disability and death worldwide as an estimated 8.6 million people fell ill with TB and 1.3 million people died from the disease in 2012.